Alzheimer's Disease Clinical Trials in Bradenton, Florida

3 studies are recruiting for alzheimer's disease in Bradenton, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Evaluate the Drug Levels, Absolute Bioavailability, Safety, Tolerability, and Immunogenicity of Single-Dose of BMS-986446 in Healthy Adults After Single-dose Administration, and Participants With Early Alzheimer's Disease After Multiple Dose Administration

    The purpose of this study is to evaluate the drug levels, absolute bioavailability, safety, tolerability, and immunogenicity of single-Dose of BMS-986446 in healthy adults after single-dose administration, and participants with early Alzheimer's Disease after multiple dose administration

    Stage
    Phase 1
    Ages
    18 to 80
    Site
    Local Institution - 0003, Bradenton, Florida
    Locations
    6 in total
    Run by
    Bristol-Myers Squibb

    See if you can join NCT07780383 on ClinicalTrials.gov

  2. A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease

    Alzheimer's disease (AD) is a progressive, irreversible neurological disorder and is the most common cause of dementia in the elderly population. Clinical symptoms of the disease may begin with occasional forgetfulness such as misplacement of items, forgetting important dates or events, and may pro…

    Stage
    Phase 1
    Ages
    50 to 90
    Site
    Key Clinical Research LLC /ID# 277800, Bradenton, Florida
    Locations
    13 in total
    Run by
    AbbVie

    See if you can join NCT07599670 on ClinicalTrials.gov

  3. A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease

    The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC in adult participants with agitation related to Alzheimer's Disease.

    Stage
    Phase 3
    Ages
    55 to 90
    Site
    Key Clinical Research, Bradenton, Florida
    Locations
    144 in total
    Run by
    Bristol-Myers Squibb

    See if you can join NCT07011745 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.